151 is the total number of securities Deep Track Capital, LP has owned. The longest Deep Track Capital, LP has owned a single stock is 8 quarters.
Period | Weighting | Quarter | |||||||
---|---|---|---|---|---|---|---|---|---|
Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
JAZZ | JAZZ PHARMACEUTICALS PLC | 8 | 8 | 4.50% | 5.74% | 7.21% | Q4 2021 | Q3 2023 | 8 |
TVTX | TRAVERE THERAPEUTICS INC | 8 | 8 | 2.54% | 4.78% | 5.70% | Q4 2021 | Q3 2023 | 8 |
IMVT | IMMUNOVANT INC | 8 | 8 | 2.42% | 3.91% | 7.24% | Q4 2021 | Q3 2023 | 8 |
BCYC | BICYCLE THERAPEUTICS PLC | 8 | 8 | 2.46% | 3.53% | 5.22% | Q4 2021 | Q3 2023 | 8 |
BEAM | BEAM THERAPEUTICS INC | 8 | 8 | 0.94% | 2.31% | 3.94% | Q4 2021 | Q3 2023 | 8 |
FDMT | 4D MOLECULAR THERAPEUT... | 8 | 8 | 1.18% | 1.96% | 2.94% | Q4 2021 | Q3 2023 | 8 |
RPTX | REPARE THERAPEUTICS INC | 8 | 8 | 1.10% | 1.92% | 3.13% | Q4 2021 | Q3 2023 | 8 |
VRDN | VIRIDIAN THERAPEUTICS INC | 8 | 8 | 0.89% | 1.58% | 2.17% | Q4 2021 | Q3 2023 | 8 |
DYN | DYNE THERAPEUTICS INC | 8 | 8 | 0.83% | 1.51% | 2.16% | Q4 2021 | Q3 2023 | 8 |
SLN | SILENCE THERAPEUTICS PLC | 8 | 8 | 0.50% | 0.92% | 1.60% | Q4 2021 | Q3 2023 | 8 |
ABOS | ACUMEN PHARMACEUTICALS... | 8 | 8 | 0.40% | 0.89% | 1.74% | Q4 2021 | Q3 2023 | 8 |
GHRS | GH RESEARCH PLC | 8 | 8 | 0.16% | 0.35% | 0.82% | Q4 2021 | Q3 2023 | 8 |
IPSC | CENTURY THERAPEUTICS INC | 8 | 8 | 0.04% | 0.31% | 0.75% | Q4 2021 | Q3 2023 | 8 |
AGEN | AGENUS INC | 7 | 7 | 1.38% | 2.24% | 2.84% | Q1 2022 | Q3 2023 | 7 |
NUVB | NUVATION BIO INC | 7 | 7 | 0.39% | 0.86% | 2.44% | Q1 2022 | Q3 2023 | 7 |
VIGIL NEUROSCIENCE INC | 7 | 7 | 0.05% | 0.61% | 1.10% | Q1 2022 | Q3 2023 | 7 | |
RLMD | RELMADA THERAPEUTICS INC | 7 | 7 | 0.18% | 0.42% | 0.78% | Q1 2022 | Q3 2023 | 7 |
ISEE | IVERIC BIO INC | 6 | 6 | 2.85% | 5.29% | 7.08% | Q4 2021 | Q1 2023 | 6 |
KDNY | CHINOOK THERAPEUTICS INC | 6 | 6 | 2.70% | 3.12% | 3.94% | Q4 2021 | Q1 2023 | 6 |
DICE THERAPEUTICS INC | 6 | 6 | 0.93% | 1.68% | 2.40% | Q4 2021 | Q1 2023 | 6 | |
NRIX | NURIX THERAPEUTICS INC | 6 | 6 | 0.91% | 1.28% | 2.03% | Q2 2022 | Q3 2023 | 6 |
NKTX | NKARTA INC | 6 | 6 | 0.20% | 1.24% | 2.28% | Q4 2021 | Q1 2023 | 6 |
JNCE | JOUNCE THERAPEUTICS INC | 6 | 6 | 0.20% | 1.01% | 2.36% | Q4 2021 | Q1 2023 | 6 |
NVCR | NOVOCURE LTD | 4 | 1 | 1.56% | 4.08% | 6.13% | Q4 2021 | Q3 2023 | 5 |
SWTX | SPRINGWORKS THERAPEUTI... | 5 | 5 | 3.10% | 3.45% | 4.30% | Q3 2022 | Q3 2023 | 5 |
PLRX | PLIANT THERAPEUTICS INC | 5 | 5 | 1.34% | 2.71% | 3.74% | Q3 2022 | Q3 2023 | 5 |
VRNA | VERONA PHARMA PLC | 5 | 5 | 1.32% | 2.51% | 3.50% | Q3 2022 | Q3 2023 | 5 |
ESPR | ESPERION THERAPEUTICS ... | 5 | 5 | 1.05% | 1.81% | 2.51% | Q4 2021 | Q4 2022 | 5 |
CRNX | CRINETICS PHARMACEUTIC... | 5 | 5 | 0.81% | 1.80% | 3.81% | Q4 2021 | Q4 2022 | 5 |
NTLA | INTELLIA THERAPEUTICS INC | 5 | 5 | 0.77% | 1.38% | 2.44% | Q3 2022 | Q3 2023 | 5 |
AUTL | AUTOLUS THERAPEUTICS PLC | 4 | 1 | 0.10% | 1.09% | 1.65% | Q1 2022 | Q3 2023 | 5 |
EWTX | EDGEWISE THERAPEUTICS INC | 5 | 5 | 0.61% | 1.04% | 1.52% | Q3 2022 | Q3 2023 | 5 |
ETNB | 89BIO INC | 5 | 5 | 0.05% | 0.88% | 2.06% | Q3 2022 | Q3 2023 | 5 |
MGTA | MAGENTA THERAPEUTICS INC | 5 | 5 | 0.05% | 0.67% | 1.52% | Q4 2021 | Q4 2022 | 5 |
FULC | FULCRUM THERAPEUTICS INC | 5 | 5 | 0.24% | 0.56% | 0.99% | Q4 2021 | Q4 2022 | 5 |
INZY | INOZYME PHARMA INC | 5 | 5 | 0.14% | 0.55% | 1.02% | Q2 2022 | Q2 2023 | 5 |
HRTX | HERON THERAPEUTICS INC | 5 | 5 | 0.08% | 0.55% | 1.65% | Q3 2022 | Q3 2023 | 5 |
ASMB | ASSEMBLY BIOSCIENCES INC | 5 | 5 | 0.10% | 0.33% | 0.49% | Q4 2021 | Q4 2022 | 5 |
INSM | INSMED INC | 4 | 4 | 3.58% | 5.08% | 6.35% | Q4 2022 | Q3 2023 | 4 |
GBT | GLOBAL BLOOD THERAPEUT... | 4 | 4 | 1.02% | 4.48% | 7.66% | Q4 2021 | Q3 2022 | 4 |
IONS | IONIS PHARMACEUTICALS INC | 4 | 4 | 1.91% | 4.10% | 5.38% | Q4 2022 | Q3 2023 | 4 |
KURA | KURA ONCOLOGY INC | 4 | 4 | 1.99% | 3.12% | 4.46% | Q4 2021 | Q3 2022 | 4 |
KROS | KEROS THERAPEUTICS INC | 4 | 4 | 0.43% | 2.99% | 5.37% | Q4 2021 | Q3 2022 | 4 |
DVAX | DYNAVAX TECHNOLOGIES CORP | 4 | 4 | 1.04% | 2.84% | 3.92% | Q4 2022 | Q3 2023 | 4 |
FATE | FATE THERAPEUTICS INC | 4 | 4 | 1.35% | 2.83% | 4.97% | Q4 2021 | Q3 2022 | 4 |
GERN | GERON CORP | 4 | 4 | 0.75% | 2.21% | 3.59% | Q4 2022 | Q3 2023 | 4 |
KALV | KALVISTA PHARMACEUTICA... | 4 | 4 | 1.18% | 1.36% | 1.64% | Q4 2021 | Q3 2022 | 4 |
TCDA | TRICIDA INC | 4 | 4 | 0.56% | 1.32% | 1.74% | Q4 2021 | Q3 2022 | 4 |
ALLK | ALLAKOS INC | 4 | 4 | 0.05% | 0.92% | 1.73% | Q3 2022 | Q2 2023 | 4 |
RAPT | RAPT THERAPEUTICS INC | 4 | 4 | 0.43% | 0.84% | 1.08% | Q4 2022 | Q3 2023 | 4 |
ANAB | ANAPTYSBIO INC | 3 | 1 | 0.42% | 0.78% | 0.93% | Q1 2022 | Q3 2023 | 4 |
ASTRIA THERAPEUTICS INC | 4 | 4 | 0.30% | 0.77% | 1.14% | Q4 2022 | Q3 2023 | 4 | |
GRTS | GRITSTONE BIO INC | 4 | 4 | 0.01% | 0.67% | 1.61% | Q4 2021 | Q3 2022 | 4 |
PASG | PASSAGE BIO INC | 4 | 4 | 0.08% | 0.64% | 1.44% | Q4 2021 | Q3 2022 | 4 |
HOOK | HOOKIPA PHARMA INC | 4 | 4 | 0.04% | 0.41% | 0.74% | Q1 2022 | Q4 2022 | 4 |
ITCI | INTRA-CELLULAR THERAPI... | 3 | 3 | 3.78% | 4.52% | 5.23% | Q1 2023 | Q3 2023 | 3 |
MDGL | MADRIGAL PHARMACEUTICA... | 3 | 3 | 2.99% | 4.06% | 4.95% | Q4 2021 | Q2 2022 | 3 |
ALKS | ALKERMES PLC | 3 | 3 | 3.47% | 3.98% | 4.35% | Q1 2023 | Q3 2023 | 3 |
STRUCTURE THERAPEUTICS... | 3 | 3 | 2.59% | 3.80% | 5.09% | Q1 2023 | Q3 2023 | 3 | |
ASND | ASCENDIS PHARMA A/S | 2 | 1 | 0.76% | 2.71% | 3.78% | Q4 2021 | Q4 2022 | 3 |
BMRN | BIOMARIN PHARMACEUTICA... | 3 | 3 | 0.82% | 2.42% | 3.56% | Q2 2022 | Q4 2022 | 3 |
PACB | PACIFIC BIOSCIENCES CA... | 3 | 3 | 0.89% | 1.50% | 1.93% | Q1 2023 | Q3 2023 | 3 |
FMTX | FORMA THERAPEUTICS HLD... | 3 | 3 | 0.88% | 1.24% | 1.83% | Q1 2022 | Q3 2022 | 3 |
SAGE | SAGE THERAPEUTICS INC | 3 | 3 | 0.36% | 1.10% | 1.50% | Q4 2021 | Q2 2022 | 3 |
VERV | VERVE THERAPEUTICS INC | 2 | 1 | 0.15% | 0.89% | 1.30% | Q4 2021 | Q3 2022 | 3 |
PNT | POINT BIOPHARMA GLOBAL... | 3 | 3 | 0.70% | 0.86% | 1.17% | Q1 2023 | Q3 2023 | 3 |
TENAYA THERAPEUTICS INC | 3 | 3 | 0.18% | 0.54% | 1.02% | Q4 2021 | Q2 2022 | 3 | |
LIFE | ATYR PHARMA INC | 3 | 3 | 0.05% | 0.33% | 0.58% | Q4 2021 | Q2 2022 | 3 |
NKTR | NEKTAR THERAPEUTICS | 3 | 3 | 0.05% | 0.32% | 0.48% | Q1 2023 | Q3 2023 | 3 |
GH | GUARDANT HEALTH INC | 2 | 2 | 2.49% | 3.56% | 4.63% | Q2 2023 | Q3 2023 | 2 |
HZNP | HORIZON THERAPEUTICS P... | 2 | 2 | 2.39% | 3.27% | 4.15% | Q3 2022 | Q4 2022 | 2 |
ASND | ASCENDIS PHARMA A/S | 2 | 2 | 1.28% | 3.00% | 4.73% | Q3 2022 | Q4 2022 | 2 |
BIIB | BIOGEN INC | 2 | 2 | 2.28% | 2.89% | 3.49% | Q4 2022 | Q1 2023 | 2 |
AXSM | AXSOME THERAPEUTICS INC | 2 | 2 | 1.28% | 2.18% | 3.08% | Q2 2023 | Q3 2023 | 2 |
EDIT | EDITAS MEDICINE INC | 2 | 2 | 1.32% | 1.73% | 2.14% | Q2 2023 | Q3 2023 | 2 |
ALBO | ALBIREO PHARMA INC | 2 | 2 | 0.98% | 1.27% | 1.55% | Q3 2022 | Q4 2022 | 2 |
ANIP | ANI PHARMACEUTICALS INC | 2 | 2 | 0.90% | 1.09% | 1.28% | Q2 2023 | Q3 2023 | 2 |
AUPH | AURINIA PHARMACEUTICAL... | 2 | 2 | 0.06% | 1.01% | 1.96% | Q3 2022 | Q4 2022 | 2 |
RNA | AVIDITY BIOSCIENCES INC | 1 | 1 | 0.28% | 0.98% | 1.68% | Q4 2021 | Q4 2022 | 2 |
TERN | TERNS PHARMACEUTICALS INC | 2 | 2 | 0.44% | 0.80% | 1.16% | Q2 2023 | Q3 2023 | 2 |
ZURA BIO LTD | 2 | 2 | 0.64% | 0.80% | 0.96% | Q2 2023 | Q3 2023 | 2 | |
PTGX | PROTAGONIST THERAPEUTI... | 1 | 1 | 0.40% | 0.71% | 1.02% | Q4 2021 | Q4 2022 | 2 |
ACET | ADICET BIO INC | 2 | 2 | 0.54% | 0.70% | 0.86% | Q2 2022 | Q3 2022 | 2 |
PRTA | PROTHENA CORP PLC | 2 | 2 | 0.47% | 0.63% | 0.79% | Q2 2023 | Q3 2023 | 2 |
THIRD HARMONIC BIO INC | 2 | 2 | 0.08% | 0.59% | 1.10% | Q3 2022 | Q4 2022 | 2 | |
SDGR | SCHRODINGER INC | 2 | 2 | 0.19% | 0.58% | 0.98% | Q2 2022 | Q3 2022 | 2 |
MORF | MORPHIC HLDG INC | 2 | 2 | 0.42% | 0.50% | 0.58% | Q2 2023 | Q3 2023 | 2 |
ORCHARD THERAPEUTICS PLC | 1 | 1 | 0.26% | 0.43% | 0.61% | Q1 2023 | Q3 2023 | 2 | |
NKTR | NEKTAR THERAPEUTICS | 2 | 2 | 0.17% | 0.32% | 0.48% | Q4 2021 | Q1 2022 | 2 |
PTGX | PROTAGONIST THERAPEUTI... | 2 | 2 | 0.14% | 0.18% | 0.22% | Q1 2022 | Q2 2022 | 2 |
CMPS | COMPASS PATHWAYS PLC | 2 | 2 | 0.09% | 0.18% | 0.26% | Q2 2023 | Q3 2023 | 2 |
IMUX | IMMUNIC INC | 2 | 2 | 0.04% | 0.10% | 0.15% | Q1 2023 | Q2 2023 | 2 |
RFL | RAFAEL HLDGS INC | 2 | 2 | 0.02% | 0.06% | 0.10% | Q4 2021 | Q1 2022 | 2 |
ALNY | ALNYLAM PHARMACEUTICAL... | 1 | 1 | 4.86% | 4.86% | 4.86% | Q1 2022 | Q1 2022 | 1 |
ALNY | ALNYLAM PHARMACEUTICAL... | 1 | 1 | 4.79% | 4.79% | 4.79% | Q2 2022 | Q2 2022 | 1 |
SRPT | SAREPTA THERAPEUTICS INC | 1 | 1 | 2.87% | 2.87% | 2.87% | Q4 2022 | Q4 2022 | 1 |
RETA | REATA PHARMACEUTICALS INC | 1 | 1 | 2.72% | 2.72% | 2.72% | Q1 2023 | Q1 2023 | 1 |
HZNP | HORIZON THERAPEUTICS P... | 1 | 1 | 2.39% | 2.39% | 2.39% | Q4 2022 | Q4 2022 | 1 |
APOGEE THERAPEUTICS INC | 1 | 1 | 1.98% | 1.98% | 1.98% | Q3 2023 | Q3 2023 | 1 | |
SGEN | SEAGEN INC | 1 | 1 | 1.81% | 1.81% | 1.81% | Q1 2023 | Q1 2023 | 1 |
ACAD | ACADIA PHARMACEUTICALS... | 1 | 1 | 1.65% | 1.65% | 1.65% | Q4 2021 | Q4 2021 | 1 |
ISEE | IVERIC BIO INC | 1 | 1 | 1.64% | 1.64% | 1.64% | Q3 2022 | Q3 2022 | 1 |
ACAD | ACADIA PHARMACEUTICALS... | 1 | 1 | 1.60% | 1.60% | 1.60% | Q2 2022 | Q2 2022 | 1 |
EXEL | EXELIXIS INC | 1 | 1 | 1.54% | 1.54% | 1.54% | Q1 2023 | Q1 2023 | 1 |
ARGX | ARGENX SE | 1 | 1 | 1.53% | 1.53% | 1.53% | Q1 2023 | Q1 2023 | 1 |
HILLEVAX INC | 1 | 1 | 1.51% | 1.51% | 1.51% | Q3 2023 | Q3 2023 | 1 | |
NBIX | NEUROCRINE BIOSCIENCES... | 1 | 1 | 1.30% | 1.30% | 1.30% | Q3 2023 | Q3 2023 | 1 |
AKRO | AKERO THERAPEUTICS INC | 1 | 1 | 1.23% | 1.23% | 1.23% | Q3 2022 | Q3 2022 | 1 |
KRTX | KARUNA THERAPEUTICS INC | 1 | 1 | 1.20% | 1.20% | 1.20% | Q4 2021 | Q4 2021 | 1 |
SAGE | SAGE THERAPEUTICS INC | 1 | 1 | 1.20% | 1.20% | 1.20% | Q4 2021 | Q4 2021 | 1 |
SRRA | SIERRA ONCOLOGY INC | 1 | 1 | 0.93% | 0.93% | 0.93% | Q4 2021 | Q4 2021 | 1 |
OLMA | OLEMA PHARMACEUTICALS INC | 1 | 1 | 0.92% | 0.92% | 0.92% | Q3 2023 | Q3 2023 | 1 |
ENTA | ENANTA PHARMACEUTICALS... | 1 | 1 | 0.91% | 0.91% | 0.91% | Q1 2022 | Q1 2022 | 1 |
AMYLYX PHARMACEUTICALS... | 1 | 1 | 0.89% | 0.89% | 0.89% | Q3 2023 | Q3 2023 | 1 | |
DCPH | DECIPHERA PHARMACEUTIC... | 1 | 1 | 0.86% | 0.86% | 0.86% | Q1 2023 | Q1 2023 | 1 |
BNTX | BIONTECH SE | 1 | 1 | 0.84% | 0.84% | 0.84% | Q3 2023 | Q3 2023 | 1 |
ATRA | ATARA BIOTHERAPEUTICS INC | 1 | 1 | 0.83% | 0.83% | 0.83% | Q4 2021 | Q4 2021 | 1 |
ARDX | ARDELYX INC | 1 | 1 | 0.81% | 0.81% | 0.81% | Q3 2022 | Q3 2022 | 1 |
MRNA | MODERNA INC | 1 | 1 | 0.80% | 0.80% | 0.80% | Q3 2023 | Q3 2023 | 1 |
QURE | UNIQURE NV | 1 | 1 | 0.72% | 0.72% | 0.72% | Q1 2023 | Q1 2023 | 1 |
RXDX | PROMETHEUS BIOSCIENCES... | 1 | 1 | 0.59% | 0.59% | 0.59% | Q1 2022 | Q1 2022 | 1 |
ACRS | ACLARIS THERAPEUTICS INC | 1 | 1 | 0.57% | 0.57% | 0.57% | Q1 2023 | Q1 2023 | 1 |
VNDA | VANDA PHARMACEUTICALS INC | 1 | 1 | 0.55% | 0.55% | 0.55% | Q4 2021 | Q4 2021 | 1 |
VNDA | VANDA PHARMACEUTICALS INC | 1 | 1 | 0.55% | 0.55% | 0.55% | Q4 2021 | Q4 2021 | 1 |
SNDX | SYNDAX PHARMACEUTICALS... | 1 | 1 | 0.53% | 0.53% | 0.53% | Q4 2022 | Q4 2022 | 1 |
ORTX | ORCHARD THERAPEUTICS PLC | 1 | 1 | 0.49% | 0.49% | 0.49% | Q2 2023 | Q2 2023 | 1 |
BBIO | BRIDGEBIO PHARMA INC | 1 | 1 | 0.47% | 0.47% | 0.47% | Q4 2021 | Q4 2021 | 1 |
AGIO | AGIOS PHARMACEUTICALS INC | 1 | 1 | 0.40% | 0.40% | 0.40% | Q3 2023 | Q3 2023 | 1 |
ZNTL | ZENTALIS PHARMACEUTICA... | 1 | 1 | 0.39% | 0.39% | 0.39% | Q2 2023 | Q2 2023 | 1 |
TCDA | TRICIDA INC | 1 | 1 | 0.37% | 0.37% | 0.37% | Q3 2022 | Q3 2022 | 1 |
RETA | REATA PHARMACEUTICALS INC | 1 | 1 | 0.36% | 0.36% | 0.36% | Q3 2022 | Q3 2022 | 1 |
NKTR | NEKTAR THERAPEUTICS | 1 | 1 | 0.35% | 0.35% | 0.35% | Q1 2022 | Q1 2022 | 1 |
CNTA | CENTESSA PHARMACEUTICA... | 1 | 1 | 0.32% | 0.32% | 0.32% | Q4 2021 | Q4 2021 | 1 |
TXG | 10X GENOMICS INC | 1 | 1 | 0.29% | 0.29% | 0.29% | Q3 2023 | Q3 2023 | 1 |
AVRO | AVROBIO INC | 1 | 1 | 0.28% | 0.28% | 0.28% | Q4 2021 | Q4 2021 | 1 |
NVAX | NOVAVAX INC | 1 | 1 | 0.28% | 0.28% | 0.28% | Q3 2023 | Q3 2023 | 1 |
MOONLAKE IMMUNOTHERAPE... | 1 | 1 | 0.26% | 0.26% | 0.26% | Q2 2023 | Q2 2023 | 1 | |
VKTX | VIKING THERAPEUTICS INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q4 2022 | Q4 2022 | 1 |
CNTB | CONNECT BIOPHARMA HLDG... | 1 | 1 | 0.24% | 0.24% | 0.24% | Q4 2021 | Q4 2021 | 1 |
ONCR | ONCORUS INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q4 2021 | Q4 2021 | 1 |
ACELYRIN INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q3 2023 | Q3 2023 | 1 | |
RLMD | RELMADA THERAPEUTICS INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q3 2022 | Q3 2022 | 1 |
2SEVENTY BIO INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q1 2023 | Q1 2023 | 1 | |
ALNY | ALNYLAM PHARMACEUTICAL... | 1 | 1 | 0.14% | 0.14% | 0.14% | Q4 2021 | Q4 2021 | 1 |
SYROS PHARMACEUTICALS INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q3 2023 | Q3 2023 | 1 | |
SRRK | SCHOLAR ROCK HLDG CORP | 1 | 1 | 0.10% | 0.10% | 0.10% | Q3 2023 | Q3 2023 | 1 |
FGEN | FIBROGEN INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2023 | Q2 2023 | 1 |
IMGN | IMMUNOGEN INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q1 2023 | Q1 2023 | 1 |
MINK THERAPEUTICS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2023 | Q2 2023 | 1 | |
RETA | REATA PHARMACEUTICALS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2022 | Q4 2022 | 1 |
ETNB | 89BIO INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2023 | Q1 2023 | 1 |
Download |
The securities at the top of the list , including JAZZ PHARMACEUTICALS PLC, TRAVERE THERAPEUTICS INC, and IMMUNOVANT INC, are the highest-conviction holdings of Deep Track Capital, LP.
The conviction is calculated by counting the number of quarters a security has been reported by Deep Track Capital, LP. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Deep Track Capital, LP owns currently or has owned in the past.